|
⚲
|
| Keyboard |
| Kathryn Falberg | |
|---|---|
| Firm | |
| Address | 1500 Broadway Suite 1401 New York, NY 10036 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Nuvation Bio Inc | 021-378335 | Director | 275.3 M of 275.3 M |
||
| Aimmune Therapeutics Inc | 021-326810 | Director | 98.0 M of 98.0 M |
||
| Aimmune Therapeutics Inc | 021-307907 | Director | 156.7 M of 156.7 M |
||
| ATYR Pharma Inc | 021-237156 | Director | 76.3 M of 76.3 M |
||
| ARCA Biopharma Inc | 021-90765-4L | Executive Officer | 0.5 M of 0.5 M |
||